Neoadjuvant therapy and PCR through chemotherapy prior to surgery

Overcoming drug resistance and targeting critical pathways

Heterogeneity of tumours and the challenges of biomarker development

Targeting the PI3K/mTOR pathway

Endocrine therapy resistance and next generation sequencing

Molecular characterisation of breast cancer: the mutational landscape

Criteria required before implementation of whole genome arrays in clinical practice

Prognostic significance of progesterone receptor-positive tumour cells within luminal A breast cancer

Innovation in molecular imaging

Personalised medicine and nursing

Non invasive biomarkers for prostate cancer

Biomarker identified in relation to pazopanib in refractory urothelial cancer